Lumida
/CDXS
⌘K
Codexis Inc

Codexis Inc

CDXS
$1.47USD↑+1.74%+0.03 today

MARKET CAP

160.4M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$1 – $1

52W RANGE

$1
$3

AI Summary

Stalk
TrimMedium

CDXS remains entrenched in a Stage 4 decline under all key moving averages. Medium-term bias is bearish with no active reversal patterns, and short-term oversold support raises bounce risk. Deferred selling on any rally into declining EMA/SMA resistance is advised.

  • ↑Q2 revenue of $14.9M topped $13.8M estimate; 2026 guidance held at $72–76M
  • ↑Gross margin improved to 73%, signaling rising operational efficiency
  • ↓Net loss of $12M (−$0.13/sh) with low earnings yield indicates weak profitability
Full analysis →

Buying

5

institutions

Selling

2

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY7.28 M16.46 M+255.58 K+43.7%0.00%
MM

Millennium Management LLC

Q2 2026

BUY5.55 M12.54 M+1.55 M+92.4%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY845.43 K1.91 M+236.83 K+92.6%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW565.59 K1.28 M+565.59 K+0.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL207.38 K468.68 K+-108.92 K-9.1%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY41.86 K97.54 K+454.00+55.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL41.50 K93.79 K+-157.23 K-71.0%0.00%